Victrelis and Intron a drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Victrelis (boceprevir) and Intron a (interferon alfa-2b). Common drug interactions include anaemia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Victrelis and Intron a. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Victrelis?

Victrelis has active ingredients of boceprevir. It is often used in hepatitis c. eHealthMe is studying from 8,634 Victrelis users. Check the latest studies of Victrelis.

What is Intron a?

Intron a has active ingredients of interferon alfa-2b. eHealthMe is studying from 9,320 Intron a users. Check the latest studies of Intron a.

On Jul, 17, 2026

21 people who take Victrelis and Intron a together, and have interactions are studied.

Victrelis and Intron a drug interactions.

What are the common drug interactions of Victrelis and Intron A, by gender? *:

female:

Anaemia (lack of blood)
Ascites (accumulation of fluid in the abdominal cavity)
Drug ineffective
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Neutropenia (an abnormally low number of neutrophils)
Drug level increased
Hepatic enzyme increased
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Renal impairment (severely reduced kidney function)
Liver transplant

male:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Insomnia (sleeplessness)
Pyrexia (fever)
Tenderness (pain or discomfort when an affected area is touched)
Thyroid disorder (thyroid diseases)
Vomiting
Abdominal distension
Abdominal pain upper

What are the common drug interactions of Victrelis and Intron A, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anaemia (lack of blood)
Ascites (accumulation of fluid in the abdominal cavity)
Drug ineffective
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Neutropenia (an abnormally low number of neutrophils)
Drug level increased
Hepatic enzyme increased
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Renal impairment (severely reduced kidney function)
Liver transplant

40-49:

n/a

50-59:

Dry skin
Eyelid ptosis (falling of the upper or lower eyelid)
Fatigue (feeling of tiredness)
Pyrexia (fever)
Tenderness (pain or discomfort when an affected area is touched)
Vomiting
Weight decreased
Nausea (feeling of having an urge to vomit)
Anaemia (lack of blood)
Chills (felling of cold)

60+:

Incoherent (talking in a confused and unclear way)
Loss of consciousness
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)

What are the existing conditions these people have? *

Hepatitis Cholestatic (flow of bile from the liver is slowed or blocked): 11 people, 52.38%
Shunt Thrombosis (blood clotting at shunt): 6 people, 28.57%
Immunodeficiency Disorders: 6 people, 28.57%
Liver Disorder (liver diseases): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Victrelis and Intron a?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously